Noninvasive Diagnosis of Acute Rejection in Renal Transplant Patients Using Mass Spectrometric Analysis of Urine Samples : A Multicenter Diagnostic Phase III Trial
- Language
-
Englisch
- Identifier
-
1285140044
Contributor
Gwinner, Wilfried
Karch, Annika
Braesen, Jan H.
Khalifa, Abedalrazag A.
Metzger, Jochen
Naesens, Maarten
Van Loon, Elisabet
Anglicheau, Dany
Marquet, Pierre
Budde, Klemens
Matz, Mareen
Arns, Wolfgang
Fischereder, Michael
Habicht, Antje
Eisenberger, Ute
Mühlfeld, Anja
Busch, Martin
Wiesener, Michael
Scheffner, Irina
Koch, Armin
Karch, Annika
Braesen, Jan H.
Khalifa, Abedalrazag A.
Metzger, Jochen
Naesens, Maarten
Van Loon, Elisabet
Anglicheau, Dany
Marquet, Pierre
Budde, Klemens
Matz, Mareen
Arns, Wolfgang
Fischereder, Michael
Habicht, Antje
Eisenberger, Ute
Mühlfeld, Anja
Busch, Martin
Wiesener, Michael
Scheffner, Irina
Koch, Armin
- DOI
-
10.18154/RWTH-CONV-249863
- URN
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
10.05.2023, 10:54 AM CEST
Associated
- Gwinner, Wilfried
- Karch, Annika
- Braesen, Jan H.
- Khalifa, Abedalrazag A.
- Metzger, Jochen
- Naesens, Maarten
- Van Loon, Elisabet
- Anglicheau, Dany
- Marquet, Pierre
- Budde, Klemens
- Matz, Mareen
- Arns, Wolfgang
- Fischereder, Michael
- Habicht, Antje
- Eisenberger, Ute
- Mühlfeld, Anja
- Busch, Martin
- Wiesener, Michael
- Scheffner, Irina
- Koch, Armin
Other Objects (12)
Determinants of Successful Use of Sirolimus in Renal Transplant Patients
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
Auswirkungen von partieller und differentieller Verifikation des Krankheitsstatus auf die Planung und Auswertung von Diagnosestudien
Patientenüberleben nach Nierentransplantation im Transplantationszentrum Hannover : Entwicklung prädiktiver Modelle und Ermittlung der relevanten Risikofaktoren mittels Cox proportional hazards und Random Survival Forest Analysen
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
A new lateral flow assay to detect sIL-2R during T-cell mediated rejection after kidney transplantation
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Liposomal Delivery Improves the Efficacy of Prednisolone to Attenuate Renal Inflammation in a Mouse Model of Acute Renal Allograft Rejection
Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients
Determinants of Successful Use of Sirolimus in Renal Transplant Patients
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
Auswirkungen von partieller und differentieller Verifikation des Krankheitsstatus auf die Planung und Auswertung von Diagnosestudien
Patientenüberleben nach Nierentransplantation im Transplantationszentrum Hannover : Entwicklung prädiktiver Modelle und Ermittlung der relevanten Risikofaktoren mittels Cox proportional hazards und Random Survival Forest Analysen
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
A new lateral flow assay to detect sIL-2R during T-cell mediated rejection after kidney transplantation
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Liposomal Delivery Improves the Efficacy of Prednisolone to Attenuate Renal Inflammation in a Mouse Model of Acute Renal Allograft Rejection
Time on previous renal replacement therapy is associated with worse outcomes of COVID-19 in a regional cohort of kidney transplant and dialysis patients
Determinants of Successful Use of Sirolimus in Renal Transplant Patients
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy : an analysis of two randomized, multicenter trials
Auswirkungen von partieller und differentieller Verifikation des Krankheitsstatus auf die Planung und Auswertung von Diagnosestudien
Patientenüberleben nach Nierentransplantation im Transplantationszentrum Hannover : Entwicklung prädiktiver Modelle und Ermittlung der relevanten Risikofaktoren mittels Cox proportional hazards und Random Survival Forest Analysen
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus : an analysis from the randomized ZEUS study
Histological findings to five years after early conversion of kidney transplant patients from cyclosporine to everolimus: an analysis from the randomized ZEUS study
A new lateral flow assay to detect sIL-2R during T-cell mediated rejection after kidney transplantation
Clinical validation of a novel enzyme-linked immunosorbent spot assay-based in vitro diagnostic assay to monitor cytomegalovirus-specific cell-mediated immunity in kidney transplant recipients: a multicenter, longitudinal, prospective, observational study
An open-label, randomized trial indicates that everolimus with tacrolimus or cyclosporine is comparable to standard immunosuppression in de novo kidney transplant patients
Liposomal Delivery Improves the Efficacy of Prednisolone to Attenuate Renal Inflammation in a Mouse Model of Acute Renal Allograft Rejection